Skip to main content

and
  1. Article

    Open Access

    Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes

    The aim of this study was to compare the efficacy of vildagliptin as add-on therapy to short-term continuous subcutaneous insulin infusion (CSII) with CSII monotherapy in hospitalized patients with type 2 diab...

    Fu-** Lyu, Bing-kun Huang, Wei-juan Su, Fang-fang Yan, **-yang Zeng in Diabetes Therapy (2020)